State Street
PCSA icon

State Street’s Processa Pharmaceuticals PCSA Stock Holding History

State Street’s Portfolio PCSA Stock Details PCSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-86
Closed -$14.3K – 4395
2023
Q4 		$14.3K Hold
86
– – ﹤0.01% 4371
2023
Q3 		$10.9K Hold
86
– – ﹤0.01% 4502
2023
Q2 		$21.3K Hold
86
– – ﹤0.01% 4586
2023
Q1 		$22.7K Hold
86
– – ﹤0.01% 4668
2022
Q4 		$47.1K Hold
86
– – ﹤0.01% 4571
2022
Q3 		$97K Hold
86
– – ﹤0.01% 4474
2022
Q2 		$120K Buy
86
+3
+4% +$4.11K ﹤0.01% 4441
2022
Q1 		$125K Hold
83
– – ﹤0.01% 4570
2021
Q4 		$203K Hold
83
– – ﹤0.01% 4345
2021
Q3 		$356K Buy
83
+50
+152% +$171K ﹤0.01% 4110
2021
Q2 		$136K Buy
+33
New +$128K ﹤0.01% 4304

Other funds holding PCSA

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MSG
Main Street Group Glen Allen, Virginia $429M AUM 34.03% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.6B AUM 15.55% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $143M AUM 19.29% 1-Year Est. Return